Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06560294

Glue Embolization vs Conservative Treatment for Pelvic Congestion Syndrome

Glue Embolization Versus Conservative Treatment for Pelvic Congestion Syndrome: A Randomized Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Tanta University · Academic / Other
Sex
Female
Age
30 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to compare glue embolization and conservative treatment for pelvic congestion syndrome regarding safety and efficacy.

Detailed description

Pelvic congestion syndrome (PCS) is a common cause of chronic lower abdominal/pelvic pain, estimated to affect about 40 % of women, predominantly between the ages of 30 and 45.The treatment of PCS depends mainly on the severity of the pain. Non-steroid anti-inflammatory drugs are often used, and contraceptives have a role in cases of pain associated predominantly with menstruation. Traditionally, conservative approaches, such as pharmacotherapy with venoactive drugs like micronized purified flavonoid fraction (Daflon), have been utilized to address the symptoms of PCS. Daflon has been used to treat venous insufficiency and has demonstrated efficacy in reducing symptoms and improving the quality of life in patients with PCS. Its mechanism of action includes improving venous tone, reducing venous stasis, and exerting anti-inflammatory effects. Endovascular treatment of PCS is challenging and requires occlusion of incompetent pelvic veins.

Conditions

Interventions

TypeNameDescription
DRUGMicronized purified flavonoid fraction (Daflon ®)Patients will receive micronized purified flavonoid fraction (Daflon ®), 500 mg twice/daily for 3 months.
OTHERGlue embolizationPatients will receive transcatheter glue embolization.

Timeline

Start date
2024-08-17
Primary completion
2025-10-01
Completion
2025-10-01
First posted
2024-08-19
Last updated
2025-08-19

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06560294. Inclusion in this directory is not an endorsement.